Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
---|---|---|---|---|---|---|
Total revenue | 787.17M | 771.51M | 10.43%2.88B | 752.33M | 20.12%2.61B | 2.17B |
Total premiums earned | --786.77M | --771.12M | 10.43%2.88B | --750.72M | 20.09%2.6B | --2.17B |
Total interest income | ---- | ---- | 17.29%2.82M | --1.22M | 100.00%2.4M | --1.2M |
Other income expense | --395K | --395K | -3.11%1.5M | --395K | 0.00%1.54M | --1.54M |
Total expenses | 630.16M | 671.62M | 17.54%2.59B | 775.9M | 9.39%2.2B | 2.01B |
Net policyholder benefits and claims | --289.78M | --295.2M | 18.37%1.2B | --330.22M | 24.57%1.02B | --816.56M |
Fees and commission expense | --92K | --92K | 0.00%335K | --84K | 0.00%335K | --335K |
Selling and administrative expenses | --340.77M | --365.26M | 15.91%1.38B | --442.93M | 2.82%1.19B | --1.16B |
-Selling and marketing expense | --340.77M | --365.26M | 15.91%1.38B | --442.93M | 2.82%1.19B | --1.16B |
Other operating expenses | ---776K | --10.79M | 139.57%2.35M | --2.37M | 4.11%-5.93M | ---6.18M |
Special income (charges) | ---- | ---- | --0 | ---- | 103.58%1.54M | ---43.11M |
-Less:Other special charges | ---- | ---- | --0 | ---- | -118.59%-1.54M | --8.31M |
-Less:Write off | ---- | ---- | ---- | ---- | ---- | --34.81M |
Net non-operating interest income (expenses) | ---293K | ---280K | -9.42%-1.13M | ---308K | -19.08%-1.03M | ---865K |
-Non-operating interest income | ---- | ---- | 17.65%20K | --10K | 21.43%17K | --14K |
-Non-operating interest expense | --293K | --280K | 9.55%1.15M | --318K | 19.11%1.05M | --879K |
Income before tax | 157.01M | 99.89M | -28.10%292.17M | -23.57M | 156.46%406.39M | 158.46M |
Income tax | 60.73M | 23.41M | -36.89%95.29M | -22.8M | 183.42%150.99M | 53.28M |
Net income | 96.28M | 76.48M | -22.91%196.89M | -774K | 142.80%255.39M | 105.19M |
Net income continuous operations | --96.28M | --76.48M | -22.91%196.89M | ---774K | 142.80%255.39M | --105.19M |
Noncontrolling interests | ||||||
Net income attributable to the company | 96.28M | 76.48M | -22.91%196.89M | -774K | 142.80%255.39M | 105.19M |
Preferred stock dividends | ||||||
Other under preferred stock dividend | ||||||
Net income attributable to common stockholders | 96.28M | 76.48M | -22.91%196.89M | -774K | 142.80%255.39M | 105.19M |
Gross dividend payment | ||||||
Basic earnings per share | 34.52 | 27.91 | -22.91%98.44 | -0.2921 | 221.70%127.69 | 39.6928 |
Diluted earnings per share | 34.16 | 27.76 | -22.91%98.44 | -0.2921 | 221.70%127.69 | 39.6928 |
Dividend per share | ||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |